AUXILIUM PHARMACEUTICALS INC's ticker is and the CUSIP is 05334DAA5. A total of 37 filers reported holding AUXILIUM PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $26,508,000 | +708.7% | 25,003,000 | +900.1% | 1.07% | +695.5% |
| Q1 2014 | $3,278,000 | +18.3% | 2,500,000 | 0.0% | 0.13% | -6.9% |
| Q4 2013 | $2,771,000 | +7.3% | 2,500,000 | 0.0% | 0.14% | +20.0% |
| Q3 2013 | $2,583,000 | +77.9% | 2,500,000 | +66.7% | 0.12% | +76.5% |
| Q2 2013 | $1,452,000 | – | 1,500,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 22,144 | $24,659,000 | 1.74% |
| Baker Brothers Advisors | 87,090,000 | $96,343,000 | 1.36% |
| SYMPHONY ASSET MANAGEMENT LLC | 10,000,000 | $11,063,000 | 0.81% |
| WOLVERINE ASSET MANAGEMENT LLC | 35,608,000 | $39,670,000 | 0.78% |
| Pinnacle Holdings, LLC | 2,110,000 | $2,337,374,000 | 0.68% |
| Man Investments (CH) AG | 1,200,000 | $1,337,000 | 0.55% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 28,969,000 | $32,352,000 | 0.41% |
| Visium Asset Management, LP | 13,000,000 | $14,461,000 | 0.28% |
| PALISADE CAPITAL MANAGEMENT, LP | 7,380,000 | $8,240,000 | 0.21% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,500,000 | $2,771,000 | 0.14% |